Navigation Links
VIA Pharmaceuticals Announces Conference Call and Webcast to Discuss VIA-2291 Phase 2 Data Presentations at AHA
Date:11/6/2008

SAN FRANCISCO, Nov. 6 /PRNewswire-FirstCall/ -- VIA Pharmaceuticals, Inc. (Nasdaq: VIAP), a biotechnology company focused on the development of compounds for the treatment of cardiovascular disease, announced today that it will hold a conference call and webcast to discuss results of the VIA-2291 Phase 2 acute coronary syndrome (ACS) and carotid endarterectomy (CEA) trials presented at the American Heart Association (AHA) Scientific Sessions 2008 on Sunday, November 9. The conference call and webcast will take place on Monday, November 10, at 8:30 a.m. ET (7:30 a.m. CT).

To participate in the conference call, please dial 888-684-1280 for domestic callers and 913-312-0952 for international callers. A telephone replay of the conference call will be available through Friday, November 14, 2008. To access the replay, please dial 888-203-1112 for domestic callers and 719-457-0820 for international callers and reference conference replay passcode 1268443.

In addition, interested parties may access a live audio webcast of the presentation from the investor section of the VIA website, http://www.viapharmaceuticals.com. A replay of the presentation will be archived on the VIA website for 30 days following the presentation.

About VIA Pharmaceuticals, Inc.

VIA Pharmaceuticals, Inc. is a biotechnology company focused on the development of compounds for the treatment of cardiovascular disease. VIA is building a pipeline of small-molecule drugs that target a significant unmet medical need: reducing inflammation in the blood vessel wall, which is an underlying cause of atherosclerosis and its complications, including heart attack and stroke. The company's lead drug
'/>"/>

SOURCE VIA Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Sunesis Pharmaceuticals Presents Clinical Trial Data of Voreloxin in Patients with Acute Myeloid Leukemia and Ovarian Cancer at the Chemotherapy Foundation Symposium
2. Raptor Pharmaceuticals Provides Update on Targeting Platforms
3. Oramed Pharmaceuticals Chosen to Present Results of GLP-1 Analog Enteral Administration Study at the Diabetes Technology Societys Eighth Annual Meeting (November 13-15, 2008; Bethesda, Maryland)
4. Mpex Pharmaceuticals Announces Initiation of a Phase 2 Clinical Trial of Aerosol MP-376 in COPD
5. Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers
6. Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Next Generation Oxazolidinone at 2008 ICAAC/IDSA Joint Meeting
7. Sequoia Pharmaceuticals Presents In Vitro and First-in-Human Data Supporting Further Development of SPI-256, a Novel Investigational Protease Inhibitor
8. Minster Pharmaceuticals Plc Announces Positive Results from Phase II Trial of Migraine with Aura
9. Addrenex Pharmaceuticals Initiates Phase 2 Trial on Its Novel Hypertension Drug, ADX415
10. Oramed Pharmaceuticals Launches Phase 1A Trials of its Insulin Suppository
11. Mpex Pharmaceuticals Presents New Data on MP-376 in Cystic Fibrosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... 2015  New product launches are critical events for ... educating thought leaders about new products, Medical Affairs is ... well a new therapy performs at launch. ... consulting leader Best Practices, LLC, critical aspects of launch ... are early stage thought leader (TL) interaction, successful TL ...
(Date:7/2/2015)... July 2, 2015 According to a ... (Deep Brain Stimulation, Spinal Cord Stimulation, Transcranial Magnetic Stimulation), Application ... Forecast to 2020", published by MarketsandMarkets, the global Neuromodulation Market ... to reach $6.20 Billion by 2020, at a CAGR of ... 8 4 market data T ...
(Date:7/2/2015)... July 2, 2015 Numotion,s Board of Directors ... that Tamas Feitel has joined the Company ... after a highly successful 18 year career at GE ... strategy, profitability, and productivity to result in significant industry ... was Chief Financial Officer for GE Healthcare Global Services, ...
Breaking Medicine Technology:Medical Affairs Role in Thought Leader Education is Key Success Factor for New Product Launches in the Pharmaceutical Industry 2Neuromodulation Market Worth $6.20 Billion by 2020 2Neuromodulation Market Worth $6.20 Billion by 2020 3Neuromodulation Market Worth $6.20 Billion by 2020 4Numotion Names Tamas Feitel Chief Financial Officer 2
... Upsher-Smith Laboratories, Inc. ( http://www.upsher-smith.com ) today announced ... of USL255, its once-daily, extended-release (ER) topiramate formulation, ... of Neurology (AAN) Meeting.  One of the posters ... of immediate-release (IR) topiramate at steady state, a ...
... Inc., the global leader in cold chain visibility ... (IATA) has deemed Sensitech,s full range of temperature ... with the 53rd edition of the IATA Dangerous ... the United Nations.   The size and lithium metal ...
Cached Medicine Technology:Upsher-Smith Research Shows Unique Pharmacokinetic Profile of USL255 Extended Release Topiramate 2Upsher-Smith Research Shows Unique Pharmacokinetic Profile of USL255 Extended Release Topiramate 3Upsher-Smith Research Shows Unique Pharmacokinetic Profile of USL255 Extended Release Topiramate 4Upsher-Smith Research Shows Unique Pharmacokinetic Profile of USL255 Extended Release Topiramate 5Sensitech Inc. Products Receive Regulatory Compliance Approval from IATA 2
(Date:7/3/2015)... ... July 03, 2015 , ... The Erie County Bar ... at 1:00pm. The Association welcomed speaker C. Daniel McGillicuddy Esq. of William Mattar ... points of investigating these types of cases. , Each year, New York State ...
(Date:7/3/2015)... ... July 03, 2015 , ... Jennifer Renee Hanes, DO is the new Medical ... largest network of independent freestanding emergency rooms in the United States. , “We are ... Plantation facility,” said Executive Medical Director of First Choice Emergency Room, Dr. James M. ...
(Date:7/3/2015)... Abilene, Texas (PRWEB) , ... July 03, 2015 , ... ... published a new article this week that he says will reveal biblical truth and ... article titled “Why Does Your Bible Say Don’t Have Sex”, immediately goes into the ...
(Date:7/2/2015)... ... July 02, 2015 , ... sweetFrog Enterprises, LLC. is pleased ... is the first sweetFrog store located in Mississippi. The premium frozen yogurt chain was ... , The store, located at 104 Railroad Avenue, New Albany, MS 38652, will have ...
(Date:7/2/2015)... ... 2015 , ... Following the recent report by JAMA Internal Medicine ... overweight Americans, Samir Becic emphatically declared a war on obesity in the United States. ... said. "We must understand the magnitude of this discovery. For that reason, I am ...
Breaking Medicine News(10 mins):Health News:Attorney from William Mattar Leads Discussion on Bicycle Accidents 2Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 2Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 3Health News:Yisrayl Hawkins Explains What the Bible Really Says about Sex in New Publication This Week 2Health News:sweetfrog Opens First Location in Mississippi 2Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 2Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 3Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 4
... Assembly (WHO), begins its annual meeting on Monday with delegations ... May 22nd to the 27th//. ,Brazil and Kenya ... the WHO assembly, for more funds to combat neglected diseases, ... to introduce a resolution to overhaul the way medical research ...
... is said that researchers are going to improve the already ... They are going to develop test kits which can help ... The skin tests are to be developed at the first ... ,By the end of 2008 these kits can be ...
... has carried a recent article on the benefits ... friendship ties, //suggesting that discussing others negative attitudes ... in friendship. ,Research shows that sharing ... it promotes closeness and friendship. In their study, ...
... Ramadoss expressed satisfaction at India’s efforts to effectively curtail the ... chicken and eggs are absolutely safe to eat, since there ... is perfect to eat chickens and eggs. The poultry should ... generally boiled at 100 degrees as it is fried in ...
... Stroke Alliance for Europe (SAFE) today announced the ,launch ... research ,project, revealed at the European Stroke Conference (ESC) ... patients and caregivers, with the first results ,expected in ... Stroke Alliance for Europe (SAFE) said, ‘We ,are excited ...
... a brand new internet-based ,television show//: PharmaVentures Business ... says, ‘This show, the first in a ,monthly ... sectors with insightful analysis and debate covering major ... to topical interviews with senior ,executives and experts, ...
Cached Medicine News:Health News:Global Stroke Survey Launched 2Health News:PharmaVentures Exploits Fastest Growing Media Channel to Launch First Pharmaceutical Business Television Show 2
Manual Lensmeter....
The Marco Lensmeter 201 features internal readings for the presbyopic practitioner or those who prefer to work in subdued lighting where external readings are difficult....
... A crisp 2.3 million pixel ... the retinal surface for all ... disc evaluation for glaucoma to ... way to provide filmless, instant ...
Manual lensmeter with AO target, high and wide field eyepiece and better marking dots....
Medicine Products: